Evolution Wealth Advisors, LLC Bristol Myers Squibb CO Transaction History

Evolution Wealth Advisors, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 28, 2022	SELL	$53.63 - $62.52 $122,759 - $143,108	-2,289 Closed	0 $0
Q3 2021 Nov 09, 2021	BUY	$59.17 - $69.31 $46,448 - $54,408	785 Added 52.19%	2,289 $135,000
Q2 2021 Jul 22, 2021	BUY	$61.91 - $67.42 $804 - $876	13 Added 0.87%	1,504 $100,000
Q1 2021 Apr 20, 2021	SELL	$59.34 - $66.74 $10,443 - $11,746	-176 Reduced 10.56%	1,491 $94,000
Q4 2020 Feb 02, 2021	SELL	$57.74 - $65.43 $10,855 - $12,300	-188 Reduced 10.13%	1,667 $103,000
Q3 2020 Oct 15, 2020	BUY	$57.43 - $63.64 $31,873 - $35,320	555 Added 42.69%	1,855 $112,000
Q2 2020 Jul 27, 2020	BUY	$54.82 - $64.09 $8,826 - $10,318	161 Added 14.14%	1,300 $76,000
Q1 2020 Apr 22, 2020	SELL	$46.4 - $67.43 $10,115 - $14,699	-218 Reduced 16.06%	1,139 $63,000
Q4 2019 Feb 03, 2020	BUY	$49.21 - $64.19 $11,416 - $14,892	232 Added 20.62%	1,357 $87,000
Q3 2019 Nov 12, 2019	BUY	$42.77 - $50.71 $1,240 - $1,470	29 Added 2.65%	1,125 $57,000
Q2 2019 Jul 12, 2019	BUY	$44.62 - $49.34 $48,903 - $54,076	1,096 New	1,096 $50,000

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $126B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Evolution Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Evolution Wealth Advisors, LLC with notifications on news.